China SXT Pharmaceuticals (SXTC) Prepaid Assets (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Prepaid Assets of $372392.0 for Q1 2026, up 16.72% year-over-year from $319058.0 in Q1 2025, and up 22.04% quarter-over-quarter from $305137.0 in Q3 2025.
China SXT Pharmaceuticals (SXTC) Prepaid Assets (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Prepaid Assets history runs 9 years deep, the most recent figure standing at $372392.0 for Q1 2026.
- In Q1 2026, Prepaid Assets rose 16.72% year-over-year to $372392.0; the TTM figure through Mar 2026 stood at $372392.0 (up 16.72% YoY), while the FY2026 annual figure was $372392.0, up 16.72% from the prior year.
- Prepaid Assets for Q1 2026 stood at $372392.0, up from $305137.0 in the prior quarter.
- The five-year high for Prepaid Assets was $1.0 million in Q3 2022, with the low at $31634.0 in Q1 2024.
- The 5-year median for Prepaid Assets is $305137.0 (2025), against an average of $391621.3.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets sank 86.73% in 2023, then jumped 908.59% in 2025.
- China SXT Pharmaceuticals' Prepaid Assets stood at $1.0 million in 2022, then tumbled by 86.73% to $137978.0 in 2023, then soared by 61.63% to $223007.0 in 2024, then surged by 36.83% to $305137.0 in 2025, then advanced by 22.04% to $372392.0 in 2026.
- Business Quant data shows SXTC's Prepaid Assets at $372392.0 in Q1 2026, $305137.0 in Q3 2025, and $319058.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | China SXT Pharmaceuticals | 32,029.92 | -28.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 372,392.00 |
| Sep 30, 2025 | 305,137.00 |
| Mar 31, 2025 | 319,058.00 |
| Sep 30, 2024 | 223,007.00 |
| Mar 31, 2024 | 31,634.00 |
| Sep 30, 2023 | 137,978.00 |
| Mar 31, 2023 | 230,642.00 |
| Sep 30, 2022 | 1.04 Mn |
| Mar 31, 2022 | 864,709.00 |
| Sep 30, 2021 | 1.82 Mn |
| Mar 31, 2021 | 1.86 Mn |
| Sep 30, 2020 | 2.17 Mn |
| Mar 31, 2020 | 4.62 Mn |
| Sep 30, 2019 | 2.02 Mn |
| Mar 31, 2019 | 707,337.00 |
| Sep 30, 2018 | 725,277.00 |
| Mar 31, 2018 | 910,606.00 |